Lithuanian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 51 displayed.
1 2 3 »

Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence

Read more ››

By: GlobeNewswire - 25 Sep 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 25 Sep 2023

Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity

Read more ››

By: GlobeNewswire - 20 Sep 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 18 Sep 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 13 Sep 2023

Novo Nordisk conducts a two-for-one stock split

Read more ››

By: GlobeNewswire - 13 Sep 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 04 Sep 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 28 Aug 2023

Semaglutide 2.4 mg shows large reductions in heart failure-related symptoms and physical limitations in people with heart failure with preserved ejection fraction and obesity

Read more ››

By: GlobeNewswire - 25 Aug 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 21 Aug 2023

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobeNewswire - 18 Aug 2023

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobeNewswire - 11 Aug 2023

Novo Nordisk's sales increased by 29% in Danish kroner and by 30% at constant exchange rates to DKK 107.7 billion in the first six months of 2023

Read more ››

By: GlobeNewswire - 10 Aug 2023

Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases

Read more ››

By: GlobeNewswire - 10 Aug 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 09 Aug 2023

Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial

Read more ››

By: GlobeNewswire - 08 Aug 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 31 Jul 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 24 Jul 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 17 Jul 2023

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 10 Jul 2023

Looking for companies outside of Lithuania?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2023
- New York City: BioFuture
- BioJapan
- Melbourne: AusBioInvest 2023

Add an Event »

Latest company news

Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
25 Sep 2023 (GlobeNewswire)

Novo Nordisk A/S - share repurchase programme
25 Sep 2023 (GlobeNewswire)

Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity
20 Sep 2023 (GlobeNewswire)

Biotechgate database

About Biotechgate
The Lithuanian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com